Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer

This publication has 16 references indexed in Scilit:

• The epidermal growth factor receptor–tyrosine kinase: A promising therapeutic target in solid tumors
  Seminars in Oncology, 2003
• Radiosynthesis of ML03, a novel positron emission tomography biomarker for targeting epidermal growth factor receptor via the labeling synthon: [11C]acryloyl chloride
  Applied Radiation and Isotopes, 2003
• Labeled EGFr‐TK irreversible inhibitor (ML03): In vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug
  International Journal of Cancer, 2002
• Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET
  European Journal of Nuclear Medicine and Molecular Imaging, 2002
• Potential 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase
  Nuclear Medicine and Biology, 2001
• Epidermal growth factor-related peptides and their receptors in human malignancies
  Published by Elsevier ,2000
• Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy
  Drugs, 2000
• Radiosynthesis and Quality Assurance of 5-[124I]Iodo-2′-deoxyuridine for Functional PET Imaging of Cell Proliferation
  Published by Elsevier ,1998
• Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials
  Annals of Oncology, 1997
• Dose-response study on thyrotoxic patients undergoing positron emission tomography and radioiodine therapy
  European Journal of Nuclear Medicine and Molecular Imaging, 1994